Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-study-reveals-daily-prescription-of-5mg-of-glucocorticoid-doubles-risk-of-cardiovascular-events-for-patients-with-rheumatoid-arthritis
https://www.med.cuhk.edu.hk/press-releases/cuhk-study-reveals-daily-prescription-of-5mg-of-glucocorticoid-doubles-risk-of-cardiovascular-events-for-patients-with-rheumatoid-arthritis

CUHK study reveals daily prescription of 5mg of glucocorticoid doubles risk of cardiovascular events for patients with rheumatoid arthritis

Glucocorticoid is a potent anti-inflammatory drug used for prompt relief of synovitis symptoms, but its use remains controversial, as it increases the risk of cardiovascular disease.

The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) conducted a long-term, population-based study to examine the time- and dose-dependent effect of systemic glucocorticoid on major adverse cardiovascular events (MACE) in patients with rheumatoid arthritis (RA). Results showed patients with RA who receive 5mg or above of glucocorticoid daily are at almost twice the risk of MACE. Researchers warned there is no safe duration of use at a daily dosage ≥5 mg and that the risk of MACE increases by 7% per month. Patients are advised to consult their rheumatologists about the possibility of tapering the dose of prednisolone to ≤4 mg daily if their joint symptoms improve. Alternatively, if necessary, they may consider early initiation of advanced therapy as a means to avoid the use of steroids. Findings have been published in the international journal Annals of the Rheumatic Diseases.

 

RA patient, Professor Tam and Dr So

A CU Medicine study shows patients with rheumatoid arthritis (RA) who receive 5mg or above of glucocorticoid daily are at almost twice the risk of major adverse cardiovascular events (MACE). (From left) Mr. Tsang, patient with RA; Professor Tam Lai-shan, Head of Division of Rheumatology; and Dr So Ho,Assistant Professor in the Department of Medicine and Therapeutics at CU Medicine.

Debate over the use of glucocorticoid for patients with RA

 

RA is an inflammatory disease that causes pain, swelling, stiffness and loss of function in the joints. It occurs when the immune system, which normally defends the body from invading external organisms, turns its attack against body’s own tissue synovium (the membrane lining the joints) and causes inflammation. It is estimated that about 22,000 people suffer from RA in Hong Kong.

 

Professor Tam

Professor Tam says patients with active RA should not arbitrarily reduce or stop the use of glucocorticoid due to the fear of increased cardiovascular risk. She suggests them following doctors’ instruction and seeking further medical advice when their disease activity index stabilizes.

Professor Tam Lai-shan, Head of Division of Rheumatology and Professor in the Department of Medicine and Therapeutics at CU Medicine, explained, “Glucocorticoid is widely prescribed at the initial presentation of active RA, as it shows an immediate effect in alleviating synovitis symptoms. However, the medicine may affect blood pressure, glycaemic metabolism and lipid profile, leading to an increased risk of cardiovascular disease. That’s why there have been debates over the use of systemic glucocorticoid on patients with RA who already bear a higher cardiovascular disease risk due to chronic inflammation. Both US and European advisory bodies in rheumatology review the clinical recommendations on glucocorticoid use from time to time.”

No safe duration of glucocorticoid use ≥5 mg for patients with RA

 

The CU Medicine research team recruited data from the Hospital Authority Data Collaboration Laboratory of 12,233 patients with RA who attended public hospitals between January 2006 and December 2015, with a mean follow-up duration of 8.7 years. None the patients had suffered from MACE, including myocardial infarction, unstable angina, ischaemic or haemorrhagic cerebrovascular incident, or transient ischaemic attack at the point when they were recruited. 37.7% of the patients were prescribed glucocorticoid at the study baseline, while other patients were put on alternative antirheumatic therapeutic options. The team found that the cardiovascular disease risk increased in a time- and-dose-dependent manner for patients with RA using glucocorticoid. Here are the key findings:

 

  • There is no safe duration of glucocorticoid use ≥5 mg.
  • A daily dose of glucocorticoid ≥5 mg results in a two-fold increased risk of MACE for patients with RA, and the risk rises by 7% per month of continued consumption.
  • A low daily dose of glucocorticoid below 5mg does not appear to be associated with an increased cardiovascular disease risk.
Dr So

Dr So says their research team will study the efficacy of  glucocorticoid of 4mg or below in managing RA.

Dr So Ho, Assistant Professor of the Department of Medicine and Therapeutics at CU Medicine, said, “Our study provided answers to questions that had long been asked about dosage and duration tolerance of glucocorticoid use in patients with RA, and its cardiovascular risk. Based on our findings, we advise doctors to prescribe systemic glucocorticoid judiciously to patients with RA to balance the risks and benefits, and to discontinue or taper to less than 4mg daily as soon as possible.” 

 

Professor Tam added, “We hope the findings send a powerful message to patients with RA who are still relying on glucocorticoid. Novel antirheumatic therapeutic options have emerged over the past 20 years, such as biological or targeted synthetic disease-modifying antirheumatic drugs, which are becoming more affordable and accessible.”

Mr Tsang

Mr Tsang has been suffering from RA for more than 20 years, with pain and stiffness in joints in the morning that he describes his hands as frozen chicken wings. He received glucocorticoid and immune-system suppressant as early treatment. In 2014, he was diagnosed with heart disease. He actively changed his living habits and was later switched to biological disease-modifying antirheumatic drug to control chronic inflammation. Both his RA and heart disease conditions are well managed.

 

More Press Releases

CUHK Study Proves Achieving Sustained Minimal Disease Activity Lowers the Risk of Cardiovascular Diseases in Psoriatic Arthritis Patients

CUHK Study Proves Achieving Sustained Minimal Disease Activity Lowers the Risk of Cardiovascular Diseases in Psoriatic Arthritis Patients

Research
CUHK achieves breakthrough in using one single tricuspid catheter to repair both mitral and tricuspid valves for treating severe regurgitation

CUHK achieves breakthrough in using one single tricuspid catheter to repair both mitral and tricuspid valves for treating severe regurgitation

Research
CUHK develops an accurate machine learning model that uses big data to predict the risk of severe hypoglycemia in the next 12 months among older adults with diabetes

CUHK develops an accurate machine learning model that uses big data to predict the risk of severe hypoglycemia in the next 12 months among older adults with diabetes

Research
T-cell responses elicited by COVID-19 vaccines Comirnaty and CoronaVac provide effective protection against severe disease from different SARS-CoV-2 variants

T-cell responses elicited by COVID-19 vaccines Comirnaty and CoronaVac provide effective protection against severe disease from different SARS-CoV-2 variants

Research
CUHK identifies a new genetic marker to predict heart disease risk in people with diabetes Study finding highlights the potential of precision medicine in diabetes

CUHK identifies a new genetic marker to predict heart disease risk in people with diabetes Study finding highlights the potential of precision medicine in diabetes

Research
CU Medicine proves oral antivirals for COVID-19 can lower the risk of hospitalisation and  inpatient progression in older patients living in nursing homes

CU Medicine proves oral antivirals for COVID-19 can lower the risk of hospitalisation and inpatient progression in older patients living in nursing homes

Research
CUHK develops an efficient approach to estimate the risk of heart disease in people living with HIV

CUHK develops an efficient approach to estimate the risk of heart disease in people living with HIV

Research
CUHK study shows prediabetes in young people predicts a 90% lifetime risk of diabetes and is linked to nearly 70% higher risks of cardiovascular diseases

CUHK study shows prediabetes in young people predicts a 90% lifetime risk of diabetes and is linked to nearly 70% higher risks of cardiovascular diseases

Research
CUHK study supports continuation of renin-angiotensin system inhibitors (RASi) in patients with type 2 diabetes and advanced chronic kidney disease to reduce major cardiorenal complications

CUHK study supports continuation of renin-angiotensin system inhibitors (RASi) in patients with type 2 diabetes and advanced chronic kidney disease to reduce major cardiorenal complications

Research
CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

Research
HKUMed-CU Medicine joint study shows that vaccinated individuals develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than the unvaccinated after an Omicron infection

HKUMed-CU Medicine joint study shows that vaccinated individuals develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than the unvaccinated after an Omicron infection

Research
International study led by CU Medicine highlights significant global incidence of newly diagnosed type 1 diabetes among adults much higher than previously believed

International study led by CU Medicine highlights significant global incidence of newly diagnosed type 1 diabetes among adults much higher than previously believed

Research
40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

Research
CUHK and International Experts in Diabetes Care Joined Hands for Four Years Developing a Multicomponent, Integrated Strategy for Diabetes under The Lancet

CUHK and International Experts in Diabetes Care Joined Hands for Four Years Developing a Multicomponent, Integrated Strategy for Diabetes under The Lancet

International collaboration
CU Medicine Studies Reveal Diabetes Death and Complication Rates Declining - but Not in the Young

CU Medicine Studies Reveal Diabetes Death and Complication Rates Declining - but Not in the Young

Research
CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

Research
Inaugural Collaboration between CUHK and AstraZeneca on Diabetic Kidney Disease Research Advancing a Global Strategy Against Diabetic Kidney Disease

Inaugural Collaboration between CUHK and AstraZeneca on Diabetic Kidney Disease Research Advancing a Global Strategy Against Diabetic Kidney Disease

International collaboration
Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Research
Multicomponent Frailty Prevention Programme Reduces Frailty Over 80% of Pre-frail Elderly Reverse to Robust Phenotype

Multicomponent Frailty Prevention Programme Reduces Frailty Over 80% of Pre-frail Elderly Reverse to Robust Phenotype

Research
CUHK Launches a Population-based Programme to Evaluate and Track Brain Health Status  of 5,000 Hong Kong Residents for Free

CUHK Launches a Population-based Programme to Evaluate and Track Brain Health Status of 5,000 Hong Kong Residents for Free

Research
CUHK Study Suggests Preoperative Screening for Obstructive Sleep Apnoea to  Lower Risk of Postoperative Cardiovascular Events

CUHK Study Suggests Preoperative Screening for Obstructive Sleep Apnoea to Lower Risk of Postoperative Cardiovascular Events

Research
CUHK Establishes Margaret K.L. Cheung Research Centre for Management of Parkinsonism  To Develop Innovative Solutions to Slow Disease Progression

CUHK Establishes Margaret K.L. Cheung Research Centre for Management of Parkinsonism To Develop Innovative Solutions to Slow Disease Progression

Research
CUHK Conducts World’s First Family Study on Rapid Eye Movement Sleep Behaviour Disorder to Investigate Familial Link with Parkinson’s Disease

CUHK Conducts World’s First Family Study on Rapid Eye Movement Sleep Behaviour Disorder to Investigate Familial Link with Parkinson’s Disease

Research
CUHK Study Proves Low-Dose Tricyclic Antidepressant (TCA) Effective in Treating Patients with Refractory Functional Dyspepsia

CUHK Study Proves Low-Dose Tricyclic Antidepressant (TCA) Effective in Treating Patients with Refractory Functional Dyspepsia

Research
CUHK Study Reveals 1 in 6 Diabetic Patients Project Rapid Renal Function Decline

CUHK Study Reveals 1 in 6 Diabetic Patients Project Rapid Renal Function Decline

Research
CUHK Studies Alert Mothers to Pregnancy Weight Gain

CUHK Studies Alert Mothers to Pregnancy Weight Gain

Research
CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

Research
CUHK Pioneers in Developing Standardised Tests for Screening Cognitive Impairment in the Ageing Population in Hong Kong

CUHK Pioneers in Developing Standardised Tests for Screening Cognitive Impairment in the Ageing Population in Hong Kong

Clinical service
CUHK Discovers an Essential Oncogene in Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma

CUHK Discovers an Essential Oncogene in Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma

Research
CUHK Study Reveals Patients with Recovery of Hepatitis B Still at Risk of Liver Cancer

CUHK Study Reveals Patients with Recovery of Hepatitis B Still at Risk of Liver Cancer

Research
CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

Research
CUHK Launches World’s First Study Utilizing Retinal Imaging for Alzheimer’s Disease Screening in Chinese Population

CUHK Launches World’s First Study Utilizing Retinal Imaging for Alzheimer’s Disease Screening in Chinese Population

Research
CUHK Sees Atrial Fibrillation-related Stroke Cases 3 Times Higher Over 15 Years

CUHK Sees Atrial Fibrillation-related Stroke Cases 3 Times Higher Over 15 Years

Research
CUHK Proves Efficacy of Home-Based Management Approach of Obstructive Sleep Apnoea Applicable to 50% of Public Hospital Adult Cases with Waiting Time Reduced by 80%

CUHK Proves Efficacy of Home-Based Management Approach of Obstructive Sleep Apnoea Applicable to 50% of Public Hospital Adult Cases with Waiting Time Reduced by 80%

Research
CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

Research
CUHK Recommends Oral Glucose Tolerance Test for All Pregnant Women Study Reveals Children of Women with Gestational Diabetes Mellitus Have 3-Fold Diabetes Risk

CUHK Recommends Oral Glucose Tolerance Test for All Pregnant Women Study Reveals Children of Women with Gestational Diabetes Mellitus Have 3-Fold Diabetes Risk

Research
CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

Research
CUHK Reveals Non-Alcoholic Fatty Liver Disease Afflicts Even the Non-Obese

CUHK Reveals Non-Alcoholic Fatty Liver Disease Afflicts Even the Non-Obese

Research
CUHK Professor Receives World Honour For Stroke Services Pioneering an Innovative 3-in-1 Multi-Target Therapy to Repair Damaged Brain After Stroke and Enhance Functional Recovery

CUHK Professor Receives World Honour For Stroke Services Pioneering an Innovative 3-in-1 Multi-Target Therapy to Repair Damaged Brain After Stroke and Enhance Functional Recovery

Awards and honors
CUHK Discovers Fatty Liver Causing Severe Liver Fibrosis or Cirrhosis in 1 Out of 5 Diabetic Patients

CUHK Discovers Fatty Liver Causing Severe Liver Fibrosis or Cirrhosis in 1 Out of 5 Diabetic Patients

Research
CUHK Opens Therese Pei Fong Chow Research Centre for Prevention of Dementia and Establishes a One-stop Online Platform to Provide Information on Dementia

CUHK Opens Therese Pei Fong Chow Research Centre for Prevention of Dementia and Establishes a One-stop Online Platform to Provide Information on Dementia

Research
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK Sets up the Global First Research Registry on Early Onset Dementia in Chinese Population

CUHK Sets up the Global First Research Registry on Early Onset Dementia in Chinese Population

Research
CUHK and HKU Researchers Introduce 3D Printing Technology in Complex Cardiac Surgery Procedures

CUHK and HKU Researchers Introduce 3D Printing Technology in Complex Cardiac Surgery Procedures

Research
CUHK Jointly Discovers New Therapeutic Solution for Minor Stroke in Global Study with over 30 Countries

CUHK Jointly Discovers New Therapeutic Solution for Minor Stroke in Global Study with over 30 Countries

Research
CUHK Sees Early Evaluation of TIA Patients Reduce Rate of Stroke by 70% in a Global Study of 21 Countries

CUHK Sees Early Evaluation of TIA Patients Reduce Rate of Stroke by 70% in a Global Study of 21 Countries

Research
CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

Research
Asia’s First Research by CUHK on Patients’ Lifestyle Reveals Personalised Modification Programme Effective in Reducing Severity of OSA

Asia’s First Research by CUHK on Patients’ Lifestyle Reveals Personalised Modification Programme Effective in Reducing Severity of OSA

Research
CUHK Screening Reveals 1 in 3 Older Adults in Community Suffer Brain Small Vessel Disease, Early Prevention Recommended

CUHK Screening Reveals 1 in 3 Older Adults in Community Suffer Brain Small Vessel Disease, Early Prevention Recommended

Clinical service
CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

Research
CUHK Introduces High Frequency Oscillations to Determine Resection Margin Increases the Effectiveness of Complex Epilepsy Surgery by around 30%

CUHK Introduces High Frequency Oscillations to Determine Resection Margin Increases the Effectiveness of Complex Epilepsy Surgery by around 30%

Surgical advancement
CUHK Highlights the Significance of Hospital Infection Control System in Controlling MERS

CUHK Highlights the Significance of Hospital Infection Control System in Controlling MERS

Research
CUHK Advocates Stringent Control of Cardiovascular Risks for Reopening of Narrowed Brain Arteries - A New Paradigm to Prevent Recurrent Stroke (Available in Chinese only)

CUHK Advocates Stringent Control of Cardiovascular Risks for Reopening of Narrowed Brain Arteries - A New Paradigm to Prevent Recurrent Stroke (Available in Chinese only)

Research
CUHK Latest Research Reveals over 100,000 New Non-alcoholic Fatty Liver Cases in Hong Kong Annually

CUHK Latest Research Reveals over 100,000 New Non-alcoholic Fatty Liver Cases in Hong Kong Annually

Research
CUHK Study Reveals Peer Support Can Reduce Hospital Admission of Distressed Diabetes Patients

CUHK Study Reveals Peer Support Can Reduce Hospital Admission of Distressed Diabetes Patients

Research
Joint Study by CUHK and HKSH Reveals Patients with Comorbid REM Sleep Behavior Disorder and Depression may Suffer from Early-stage Neurodegeneration

Joint Study by CUHK and HKSH Reveals Patients with Comorbid REM Sleep Behavior Disorder and Depression may Suffer from Early-stage Neurodegeneration

Research
CUHK Advocates Atrial Fibrillation Screening and Drug Education to Reduce Risk of Stroke among Elderly

CUHK Advocates Atrial Fibrillation Screening and Drug Education to Reduce Risk of Stroke among Elderly

Clinical service
Screening Reveals Over 50% Community-dwelling Population Aged 65 or above are Pre-frail

Screening Reveals Over 50% Community-dwelling Population Aged 65 or above are Pre-frail

Research
Risk of Diabetes Patients Having Depression Doubles That of the General Public CUHK Advocates Timely Assessment of Diabetes Patients’ Mental Health Conditions

Risk of Diabetes Patients Having Depression Doubles That of the General Public CUHK Advocates Timely Assessment of Diabetes Patients’ Mental Health Conditions

Research
Radiotherapy to Head and Neck Raises Risk for Stroke CUHK Proved Effectiveness of Carotid Angioplasty and Stenting

Radiotherapy to Head and Neck Raises Risk for Stroke CUHK Proved Effectiveness of Carotid Angioplasty and Stenting

Research
CUHK and PolyU Jointly Introduce TeleStroke for 24-hour Thrombolysis Service at Prince of Wales Hospital

CUHK and PolyU Jointly Introduce TeleStroke for 24-hour Thrombolysis Service at Prince of Wales Hospital

Clinical service
CUHK Releases Research Results on Employment Status of Hong Kong Chronic Kidney Disease (CKD) Dialysis Patients and Promotes Predialysis Education Programme for Mid to Late Stage CKD patients

CUHK Releases Research Results on Employment Status of Hong Kong Chronic Kidney Disease (CKD) Dialysis Patients and Promotes Predialysis Education Programme for Mid to Late Stage CKD patients

Research
CUHK Announces Latest Medical Treatment for Minor Stroke

CUHK Announces Latest Medical Treatment for Minor Stroke

Research
Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Research
CUHK-HCC Score Accurately Predicts Risk of Liver Cancer in Chronic Hepatitis B Patients Receiving Antiviral Therapy

CUHK-HCC Score Accurately Predicts Risk of Liver Cancer in Chronic Hepatitis B Patients Receiving Antiviral Therapy

Research
CUHK and Shanghai Jiao Tong University Discover Genetic Predictor of Diabetes in Chinese Patients

CUHK and Shanghai Jiao Tong University Discover Genetic Predictor of Diabetes in Chinese Patients

Research
CUHK Pioneers the Use of 3D Echocardiography to Identify At-Risk Mitral Valve Prolapse Patients

CUHK Pioneers the Use of 3D Echocardiography to Identify At-Risk Mitral Valve Prolapse Patients

Research
CUHK Advocates Palliative Care for Advanced Dementia Patients with Swallowing Problems

CUHK Advocates Palliative Care for Advanced Dementia Patients with Swallowing Problems

Research
CUHK Study Reveals High Salt Intake Will Lead to High Blood Pressure and Higher Risk of Stroke

CUHK Study Reveals High Salt Intake Will Lead to High Blood Pressure and Higher Risk of Stroke

Research
CUHK Launches Territory-wide Sleep Health Education Campaign to Promote Healthy Sleep and Healthy School Life

CUHK Launches Territory-wide Sleep Health Education Campaign to Promote Healthy Sleep and Healthy School Life

Health Campaign
CUHK and HKU's Collaborative Research Discovers Novel Epilepsy Genetic Markers

CUHK and HKU's Collaborative Research Discovers Novel Epilepsy Genetic Markers

Research
CUHK Advocates Early Detection of Chronic Kidney Diseases Joined by Leading Nephrologists to Make Sound Recommendations

CUHK Advocates Early Detection of Chronic Kidney Diseases Joined by Leading Nephrologists to Make Sound Recommendations

Research
CUHK Proves the Potent Efficacy of Stenting for Carotid Artery Narrowing and Cardiac Contractility Modulation for Heart Failure

CUHK Proves the Potent Efficacy of Stenting for Carotid Artery Narrowing and Cardiac Contractility Modulation for Heart Failure

Research
Three CUHK Scholars Named Croucher Senior Research Fellow 2011-12

Three CUHK Scholars Named Croucher Senior Research Fellow 2011-12

Awards and honors
CUHK Research Findings on Severe Human Swine Flu in Hong Kong

CUHK Research Findings on Severe Human Swine Flu in Hong Kong

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.